C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $301,065 | -51.4% | 161,863 | -28.1% | 0.00% | – |
| Q2 2023 | $619,278 | -26.4% | 225,192 | -16.0% | 0.00% | – |
| Q1 2023 | $841,730 | +312.8% | 268,067 | +675.6% | 0.00% | – |
| Q4 2022 | $203,910 | -58.0% | 34,561 | -37.6% | 0.00% | – |
| Q3 2022 | $486,000 | +133.7% | 55,370 | +100.6% | 0.00% | – |
| Q2 2022 | $208,000 | -91.9% | 27,600 | -74.0% | 0.00% | – |
| Q1 2022 | $2,572,000 | -23.2% | 106,020 | +1.9% | 0.00% | – |
| Q4 2021 | $3,350,000 | -46.4% | 104,058 | -25.6% | 0.00% | -100.0% |
| Q3 2021 | $6,252,000 | +215.1% | 139,915 | +166.9% | 0.00% | – |
| Q2 2021 | $1,984,000 | +755.2% | 52,427 | +735.9% | 0.00% | – |
| Q1 2021 | $232,000 | – | 6,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $15,939,000 | 8.67% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $54,406,000 | 3.42% |
| Darwin Global Management, Ltd. | 228,595 | $7,573,000 | 2.11% |
| Asymmetry Capital Management, L.P. | 139,343 | $4,616,000 | 2.10% |
| Cormorant Asset Management, LP | 2,490,065 | $80,021,000 | 1.90% |
| Logos Global Management LP | 477,928 | $15,834,000 | 1.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 443,824 | $14,601,000 | 1.30% |
| Soleus Capital Management, L.P. | 268,548 | $8,897,000 | 1.17% |
| P.A.W. CAPITAL CORP | 40,000 | $1,325,000 | 1.17% |
| RTW INVESTMENTS, LP | 2,149,228 | $68,679,000 | 1.15% |